\relax 
\providecommand\hyper@newdestlabel[2]{}
\providecommand\HyperFirstAtBeginDocument{\AtBeginDocument}
\HyperFirstAtBeginDocument{\ifx\hyper@anchor\@undefined
\global\let\oldcontentsline\contentsline
\gdef\contentsline#1#2#3#4{\oldcontentsline{#1}{#2}{#3}}
\global\let\oldnewlabel\newlabel
\gdef\newlabel#1#2{\newlabelxx{#1}#2}
\gdef\newlabelxx#1#2#3#4#5#6{\oldnewlabel{#1}{{#2}{#3}}}
\AtEndDocument{\ifx\hyper@anchor\@undefined
\let\contentsline\oldcontentsline
\let\newlabel\oldnewlabel
\fi}
\fi}
\global\let\hyper@last\relax 
\gdef\HyperFirstAtBeginDocument#1{#1}
\providecommand\HyField@AuxAddToFields[1]{}
\providecommand\HyField@AuxAddToCoFields[2]{}
\citation{Leclerc:2009ep}
\@writefile{toc}{\contentsline {section}{\numberline {1}Introduction and Summary}{3}{section.1}}
\@writefile{toc}{\contentsline {section}{\numberline {2}High level description}{5}{section.2}}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.1}Conceptual structure}{5}{subsection.2.1}}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.2}Implemented Features}{5}{subsection.2.2}}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.3}Future implementations}{5}{subsection.2.3}}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.4}Weaknesses}{5}{subsection.2.4}}
\@writefile{toc}{\contentsline {section}{\numberline {3}Demographics}{6}{section.3}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.1}Births}{6}{subsection.3.1}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.2}Youth arrival at sexual debut}{6}{subsection.3.2}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.3}Death}{7}{subsection.3.3}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.4}Immigration}{7}{subsection.3.4}}
\@writefile{toc}{\contentsline {section}{\numberline {4}Partnerships}{7}{section.4}}
\@writefile{toc}{\contentsline {subsection}{\numberline {4.1}Partnerships formation}{7}{subsection.4.1}}
\@writefile{lof}{\contentsline {figure}{\numberline {1}{\ignorespaces Death hazard. The red dot represents the age of HIV acquisition. Vertical dashed lines are set at 5, 7 and 10 years after HIV acquisition.}}{8}{figure.1}}
\newlabel{fig:deathHazard}{{1}{8}{Death hazard. The red dot represents the age of HIV acquisition. Vertical dashed lines are set at 5, 7 and 10 years after HIV acquisition}{figure.1}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.1.1}Formation algorithm}{8}{subsubsection.4.1.1}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.1.2}Formation success random variable ($\Phi $)}{9}{subsubsection.4.1.2}}
\newlabel{formationSuccessFormula}{{4.1.2}{9}{Formation success random variable ($\Phi $)}{subsubsection.4.1.2}{}}
\newlabel{probaFormation}{{3}{9}{Formation success random variable ($\Phi $)}{equation.4.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2}{\ignorespaces Partnership formation probability component for age and age gap}}{10}{figure.2}}
\newlabel{fig:formationAge}{{2}{10}{Partnership formation probability component for age and age gap}{figure.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3}{\ignorespaces Partnership formation probability component for risk group and partnership deficit}}{10}{figure.3}}
\newlabel{fig:formationRiskDeficit}{{3}{10}{Partnership formation probability component for risk group and partnership deficit}{figure.3}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.1.3}Maximum number of sexual partners}{11}{subsubsection.4.1.3}}
\@writefile{toc}{\contentsline {subsection}{\numberline {4.2}Spousal union}{11}{subsection.4.2}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.2.1}Determinants}{11}{subsubsection.4.2.1}}
\newlabel{eqSpouse}{{4}{11}{Determinants}{equation.4.4}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.2.2}Algorithm}{12}{subsubsection.4.2.2}}
\@writefile{toc}{\contentsline {subsection}{\numberline {4.3}Partnerships dissolution}{13}{subsection.4.3}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.3.1}Dissolution algorithm}{13}{subsubsection.4.3.1}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.3.2}Dissolution success random variable ($\Psi $)}{13}{subsubsection.4.3.2}}
\newlabel{dissolutionSuccessFormula}{{4.3.2}{13}{Dissolution success random variable ($\Psi $)}{subsubsection.4.3.2}{}}
\citation{x}
\citation{BREWIS:2005gk}
\newlabel{probaDissolution}{{5}{14}{Dissolution success random variable ($\Psi $)}{equation.4.5}{}}
\@writefile{toc}{\contentsline {section}{\numberline {5}Sexual intercourses}{14}{section.5}}
\@writefile{lof}{\contentsline {figure}{\numberline {4}{\ignorespaces .}}{15}{figure.4}}
\newlabel{fig:sexDistribution}{{4}{15}{}{figure.4}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.1}Total number of sex acts}{15}{subsection.5.1}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.2}Distribution of sex acts among partner types}{16}{subsection.5.2}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.3}Distributing the number of sex acts between partners}{17}{subsection.5.3}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.4}Distributing sex acts types}{17}{subsection.5.4}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.5}Limits on the number of sex acts for females}{18}{subsection.5.5}}
\@writefile{toc}{\contentsline {subsection}{\numberline {5.6}Sex acts of males with no partnership}{18}{subsection.5.6}}
\@writefile{toc}{\contentsline {section}{\numberline {6}Commercial sex workers}{19}{section.6}}
\@writefile{toc}{\contentsline {subsection}{\numberline {6.1}Recruitment}{19}{subsection.6.1}}
\@writefile{toc}{\contentsline {subsection}{\numberline {6.2}Cessation}{19}{subsection.6.2}}
\@writefile{toc}{\contentsline {section}{\numberline {7}Disease transmission}{19}{section.7}}
\citation{Weiss:2006hoa}
\citation{Tobian:2009kp}
\citation{Tobian:2010tr}
\@writefile{toc}{\contentsline {subsection}{\numberline {7.1}Infectivity curve and susceptibility factor}{20}{subsection.7.1}}
\@writefile{lot}{\contentsline {table}{\numberline {1}{\ignorespaces Reduced susceptibility for male circumcision. A susceptibility factor of 1 means circumcision has no effect on susceptibility.}}{20}{table.1}}
\newlabel{tab:circum}{{1}{20}{Reduced susceptibility for male circumcision. A susceptibility factor of 1 means circumcision has no effect on susceptibility}{table.1}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {7.2}Probability of sexual transmission}{20}{subsection.7.2}}
\citation{Pilcher:2007wr}
\@writefile{lot}{\contentsline {table}{\numberline {2}{\ignorespaces Increased susceptibility matrix $C$ (at the population level). Columns represent STIs already infecting the individual and rows STIs exposed to. Effect between STIs other than HIV is assumed neutral (OR=1) because of a lack of literature investigating this effect. \textbf  {\leavevmode {\color  {OrangeRed}double check}}}}{21}{table.2}}
\newlabel{default}{{2}{21}{Increased susceptibility matrix $C$ (at the population level). Columns represent STIs already infecting the individual and rows STIs exposed to. Effect between STIs other than HIV is assumed neutral (OR=1) because of a lack of literature investigating this effect. \warning {double check}}{table.2}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {7.3}Probabilities of transmission for every STI}{21}{subsection.7.3}}
\newlabel{sec:probaTransmission}{{7.3}{21}{Probabilities of transmission for every STI}{subsection.7.3}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {7.3.1}HIV}{21}{subsubsection.7.3.1}}
\citation{Tronstein:2011vs}
\citation{xxx}
\@writefile{lot}{\contentsline {table}{\numberline {3}{\ignorespaces HIV increased infectiousness upon co-infection with another STI ($RI_{coSTI}(s)$). Values are fraction of the peak infectiousness that occurs during the early acute stage of HIV natural history.\textbf  {\leavevmode {\color  {OrangeRed} Based on few studies (Cohen 1997, Dyer 1998). Assume ulcerative STI at 0.7 and non-ulceratives at 0.5}}}}{22}{table.3}}
\newlabel{Table:rebound}{{3}{22}{HIV increased infectiousness upon co-infection with another STI ($RI_{coSTI}(s)$). Values are fraction of the peak infectiousness that occurs during the early acute stage of HIV natural history.\warning { Based on few studies (Cohen 1997, Dyer 1998). Assume ulcerative STI at 0.7 and non-ulceratives at 0.5}}{table.3}{}}
\citation{Tronstein:2011vs}
\citation{Tobian:2009kp}
\citation{Stanley:2011dd}
\citation{Baussano:2013dh}
\citation{Tobian:2009kp}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {7.3.2}HSV2}{23}{subsubsection.7.3.2}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {7.3.3}HPV}{23}{subsubsection.7.3.3}}
\citation{Geisler:2010bc}
\citation{Althaus:2011dc}
\citation{Hontelez:2013bc}
\citation{Althaus:2012gg}
\citation{Geisler:2010bc}
\citation{Althaus:2011dc}
\citation{Korenromp:2002gt}
\citation{Kretzschmar:1996ur}
\@writefile{lof}{\contentsline {figure}{\numberline {5}{\ignorespaces Infectivity curve for HPV. Dash line represent persistent infection.}}{24}{figure.5}}
\newlabel{fig:ICHPV}{{5}{24}{Infectivity curve for HPV. Dash line represent persistent infection}{figure.5}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {7.3.4}Chlamydia (Ct)}{24}{subsubsection.7.3.4}}
\citation{Korenromp:2002gt}
\citation{Kretzschmar:2009cd}
\citation{Ison:2011eg}
\citation{Kretzschmar:1996ur}
\citation{Korenromp:2002gt}
\citation{Ison:2011eg}
\citation{Kretzschmar:1996ur}
\citation{Korenromp:2002gt}
\@writefile{lof}{\contentsline {figure}{\numberline {6}{\ignorespaces Infectivity curve for Chlamydia. Dash line represents asymptomatic infection.}}{25}{figure.6}}
\newlabel{fig:ICCt}{{6}{25}{Infectivity curve for Chlamydia. Dash line represents asymptomatic infection}{figure.6}{}}
\citation{Kretzschmar:1996ur}
\citation{Chen:2010hx}
\citation{Korenromp:2002gt}
\citation{Kent:2008ch}
\citation{Horvath:2011fw}
\citation{Horvath:2011fw}
\citation{Kent:2008ch}
\citation{Horvath:2011fw}
\citation{Horvath:2011fw}
\citation{Kent:2008ch}
\citation{Horvath:2011fw}
\citation{Kent:2008ch}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {7.3.5}Neisseria Gonorrhoeae (Ng)}{26}{subsubsection.7.3.5}}
\@writefile{lof}{\contentsline {figure}{\numberline {7}{\ignorespaces Infectivity curve for Gonorrohea.}}{26}{figure.7}}
\newlabel{fig:ICNg}{{7}{26}{Infectivity curve for Gonorrohea}{figure.7}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {7.3.6}Syphilis (Treponema pallidum, Tp)}{26}{subsubsection.7.3.6}}
\citation{Horvath:2011fw}
\citation{Kent:2008ch}
\citation{Sakuma:2011gx}
\citation{Morse:1989io}
\citation{Sakuma:2011gx}
\citation{Spinola:2002kn}
\citation{Sakuma:2011gx}
\citation{Spinola:2002kn}
\citation{Hammond:1980uz}
\citation{Spinola:2002kn}
\@writefile{lof}{\contentsline {figure}{\numberline {8}{\ignorespaces Infectivity curve for Syphilis. The thin curve in the secondary syphilis stage represents the case when highly infectious condolymata develop.}}{28}{figure.8}}
\newlabel{fig:ICTp}{{8}{28}{Infectivity curve for Syphilis. The thin curve in the secondary syphilis stage represents the case when highly infectious condolymata develop}{figure.8}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {7.3.7}Chancroids (Hd)}{28}{subsubsection.7.3.7}}
\citation{Jirovec:1968vi}
\citation{Pellicane:2011dk}
\citation{Schwebke:2004bq}
\citation{Krieger:1995ur}
\citation{Petrin:1998te}
\@writefile{lof}{\contentsline {figure}{\numberline {9}{\ignorespaces Infectivity curve for Chancroid (Hd). Dash line represents asymptomatic infection.}}{29}{figure.9}}
\newlabel{fig:ICHd}{{9}{29}{Infectivity curve for Chancroid (Hd). Dash line represents asymptomatic infection}{figure.9}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {7.3.8}Trichomoniasis (Tv)}{29}{subsubsection.7.3.8}}
\citation{Petrin:1998te}
\citation{Krieger:1995ur}
\citation{Petrin:1998te}
\citation{Krieger:1995ur}
\citation{Krieger:1995ur}
\citation{Pellicane:2011dk}
\citation{Mehta:2009bh}
\citation{SobngwiTambekou:2008fs}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {7.3.9}Bacterial vag (Bv)}{30}{subsubsection.7.3.9}}
\@writefile{toc}{\contentsline {subsection}{\numberline {7.4}Mother to child transmission (MTCT)}{30}{subsection.7.4}}
\@writefile{lot}{\contentsline {table}{\numberline {4}{\ignorespaces MTCT probabilities ($d$: duration of infection)}}{30}{table.4}}
\newlabel{default}{{4}{30}{MTCT probabilities ($d$: duration of infection)}{table.4}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {10}{\ignorespaces Infectivity curve for Trichomanas vagionisis (Tv). Dash line represents asymptomatic infection.}}{31}{figure.10}}
\newlabel{fig:ICTv}{{10}{31}{Infectivity curve for Trichomanas vagionisis (Tv). Dash line represents asymptomatic infection}{figure.10}{}}
\@writefile{toc}{\contentsline {section}{\numberline {8}Treatment}{31}{section.8}}
\@writefile{toc}{\contentsline {subsection}{\numberline {8.1}Generic implementation}{31}{subsection.8.1}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {8.1.1}Treatment microbiological failure}{31}{subsubsection.8.1.1}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {8.1.2}Adherence}{32}{subsubsection.8.1.2}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {8.1.3}Treatment reduction effect}{32}{subsubsection.8.1.3}}
\@writefile{lof}{\contentsline {figure}{\numberline {11}{\ignorespaces Treatment reduction effect.}}{32}{figure.11}}
\newlabel{fig:TRE}{{11}{32}{Treatment reduction effect}{figure.11}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {8.2}Treatment each STI}{33}{subsection.8.2}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {8.2.1}Bacterial STIs}{33}{subsubsection.8.2.1}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {8.2.2}Viral STIs}{33}{subsubsection.8.2.2}}
\@writefile{toc}{\contentsline {section}{\numberline {9}Vaccination}{33}{section.9}}
\@writefile{toc}{\contentsline {section}{\numberline {10}Migrations between populations}{33}{section.10}}
\@writefile{toc}{\contentsline {section}{\numberline {11}Simulation}{33}{section.11}}
\@writefile{toc}{\contentsline {subsection}{\numberline {11.1}Calibration}{33}{subsection.11.1}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {11.1.1}Newest stuff (feb-2015)}{33}{subsubsection.11.1.1}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {11.1.2}Response variable of the Model to be calibrated}{33}{subsubsection.11.1.2}}
\@writefile{lot}{\contentsline {table}{\numberline {5}{\ignorespaces Response variables to be calibrated}}{33}{table.5}}
\newlabel{default}{{5}{33}{Response variables to be calibrated}{table.5}{}}
\@writefile{toc}{\contentsline {subsubsection}{\numberline {11.1.3}Algorithm (high-level)}{34}{subsubsection.11.1.3}}
\@writefile{toc}{\contentsline {section}{\numberline {12}Miscellaneous Notes}{35}{section.12}}
\@writefile{toc}{\contentsline {subsection}{\numberline {12.1}Pseudo-beta shape function}{35}{subsection.12.1}}
\newlabel{sec:pseudobeta}{{12.1}{35}{Pseudo-beta shape function}{subsection.12.1}{}}
\@writefile{toc}{\contentsline {section}{\numberline {13}Model Parameters Summary}{36}{section.13}}
\@writefile{lot}{\contentsline {table}{\numberline {6}{\ignorespaces Exhaustive list of all model parameters related to demographics}}{36}{table.6}}
\newlabel{tab:demogAllParam}{{6}{36}{Exhaustive list of all model parameters related to demographics}{table.6}{}}
\@writefile{lot}{\contentsline {table}{\numberline {7}{\ignorespaces Exhaustive list of all model parameters related to parterships}}{36}{table.7}}
\newlabel{tab:partnerAllParam}{{7}{36}{Exhaustive list of all model parameters related to parterships}{table.7}{}}
\bibstyle{alpha}
\bibdata{papers}
\@writefile{lot}{\contentsline {table}{\numberline {8}{\ignorespaces Exhaustive list of all model parameters related to viral STIs}}{37}{table.8}}
\newlabel{tab:STIAllParamVirus}{{8}{37}{Exhaustive list of all model parameters related to viral STIs}{table.8}{}}
\@writefile{lot}{\contentsline {table}{\numberline {9}{\ignorespaces Exhaustive list of model parameters related to bacterial STIs}}{38}{table.9}}
\newlabel{tab:STIAllParamBacteria}{{9}{38}{Exhaustive list of model parameters related to bacterial STIs}{table.9}{}}
\@writefile{lot}{\contentsline {table}{\numberline {10}{\ignorespaces Exhaustive list of model parameters related to protozoan STIs}}{39}{table.10}}
\newlabel{tab:STIAllParamProtozoa}{{10}{39}{Exhaustive list of model parameters related to protozoan STIs}{table.10}{}}
